应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NKTR 内克塔治疗
未开盘 07-31 16:00:00 EDT
21.68
-0.39
-1.77%
盘后
21.63
-0.05
-0.23%
19:57 EDT
最高
22.46
最低
21.56
成交量
36.83万
今开
21.88
昨收
22.07
日振幅
4.10%
总市值
3.75亿
流通市值
3.68亿
总股本
1,730万
成交额
808.62万
换手率
2.17%
流通股本
1,699万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
内克塔治疗盘中异动 股价大跌5.16%报23.71美元
市场透视 · 07-28
内克塔治疗盘中异动 股价大跌5.16%报23.71美元
内克塔治疗7月22日成交额为1434.03万美元
市场透视 · 07-23
内克塔治疗7月22日成交额为1434.03万美元
内克塔治疗7月21日成交额为1485.21万美元
市场透视 · 07-22
内克塔治疗7月21日成交额为1485.21万美元
内克塔治疗7月17日成交额为3353.97万美元
市场透视 · 07-18
内克塔治疗7月17日成交额为3353.97万美元
内克塔治疗7月16日成交额为2297.95万美元
市场透视 · 07-17
内克塔治疗7月16日成交额为2297.95万美元
内克塔治疗盘中异动 早盘股价大跌5.13%报23.16美元
市场透视 · 07-15
内克塔治疗盘中异动 早盘股价大跌5.13%报23.16美元
内克塔治疗盘中异动 早盘股价大跌5.04%
市场透视 · 07-14
内克塔治疗盘中异动 早盘股价大跌5.04%
内克塔治疗7月10日成交额为3959.46万美元
市场透视 · 07-11
内克塔治疗7月10日成交额为3959.46万美元
内克塔治疗盘中异动 股价大涨5.46%
市场透视 · 07-09
内克塔治疗盘中异动 股价大涨5.46%
内克塔治疗盘中异动 股价大跌5.20%报22.25美元
市场透视 · 07-08
内克塔治疗盘中异动 股价大跌5.20%报22.25美元
内克塔治疗盘中异动 早盘急速下跌5.05%
市场透视 · 07-07
内克塔治疗盘中异动 早盘急速下跌5.05%
内克塔治疗7月2日成交额为5274.27万美元
市场透视 · 07-03
内克塔治疗7月2日成交额为5274.27万美元
内克塔治疗7月1日成交额为9598.57万美元
市场透视 · 07-02
内克塔治疗7月1日成交额为9598.57万美元
内克塔治疗盘中异动 早盘股价大涨5.88%
市场透视 · 06-30
内克塔治疗盘中异动 早盘股价大涨5.88%
内克塔治疗6月26日成交额为2.17亿美元
市场透视 · 06-27
内克塔治疗6月26日成交额为2.17亿美元
美股异动 | Nektar Therapeutics(NKTR.US)大涨近30% 湿疹治疗药物临床研究取得超预期积极结果
智通财经 · 06-25
美股异动 | Nektar Therapeutics(NKTR.US)大涨近30% 湿疹治疗药物临床研究取得超预期积极结果
内克塔治疗盘中异动 快速上涨5.24%
市场透视 · 06-25
内克塔治疗盘中异动 快速上涨5.24%
创新药重磅消息!“T细胞黑马”Nektar湿疹疗效炸裂,股价单日暴涨150%
智通财经 · 06-25
创新药重磅消息!“T细胞黑马”Nektar湿疹疗效炸裂,股价单日暴涨150%
HC Wainwright & Co.:维持Nektar Therapeutics(NKTR.US)评级,由买入调整至买入评级, 目标价由6.50美元调整至120.00美元。
金融界 · 06-24
HC Wainwright & Co.:维持Nektar Therapeutics(NKTR.US)评级,由买入调整至买入评级, 目标价由6.50美元调整至120.00美元。
内克塔治疗盘中异动 早盘快速拉升5.04%
市场透视 · 06-18
内克塔治疗盘中异动 早盘快速拉升5.04%
加载更多
公司概况
公司名称:
内克塔治疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nektar Therapeutics于1990年在加州成立,并于1998年重新在特拉华州注册。该公司是一家临床阶段、研究型药物发现生物制药公司,专注于发现和开发免疫治疗领域的创新药物。在这个不断增长的领域内,该公司致力于创造新的免疫调节剂,选择性地诱导、放大、减弱或阻止免疫反应,以达到预期的治疗效果。
发行价格:
--
{"stockData":{"symbol":"NKTR","market":"US","secType":"STK","nameCN":"内克塔治疗","latestPrice":21.68,"timestamp":1753992000000,"preClose":22.07,"halted":0,"volume":368328,"hourTrading":{"tag":"盘后","latestPrice":21.6291,"preClose":21.68,"latestTime":"19:57 EDT","volume":5046,"amount":109318.9435,"timestamp":1754006227305},"delay":0,"floatShares":16985130,"shares":17301100,"eps":-9.516269,"marketStatus":"未开盘","change":-0.39,"latestTime":"07-31 16:00:00 EDT","open":21.88,"high":22.46,"low":21.555,"amount":8086199.9830559995,"amplitude":0.041006,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.516269,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":22.07,"preHourTrading":{"tag":"盘前","latestPrice":21.8,"preClose":22.145,"latestTime":"09:29 EDT","volume":540,"amount":11917.40958,"timestamp":1753968574009},"postHourTrading":{"tag":"盘后","latestPrice":21.6291,"preClose":21.68,"latestTime":"19:57 EDT","volume":5046,"amount":109318.9435,"timestamp":1754006227305},"volumeRatio":0.556802,"impliedVol":0.4741,"impliedVolPercentile":0.0924},"requestUrl":"/m/hq/s/NKTR","defaultTab":"news","newsList":[{"id":"2555708781","title":"内克塔治疗盘中异动 股价大跌5.16%报23.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555708781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555708781?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:44","pubTimestamp":1753717458,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时44分,内克塔治疗股票出现波动,股价大幅下挫5.16%。截至发稿,该股报23.71美元/股,成交量23.6647万股,换手率1.37%,振幅6.80%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.02%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823441994bf9fbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823441994bf9fbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2553818296","title":"内克塔治疗7月22日成交额为1434.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553818296","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553818296?lang=zh_cn&edition=full","pubTime":"2025-07-23 12:22","pubTimestamp":1753244572,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,内克塔治疗成交额为1434.03万美元,成交额较昨日减少3.45%,当日成交量为58.01万股。内克塔治疗于2025年7月22日跌1.25%,报24.48美元,该股过去5个交易日涨2.86%,年初至今涨75.48%,过去60日涨121.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723122254a45decb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723122254a45decb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2553251289","title":"内克塔治疗7月21日成交额为1485.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553251289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553251289?lang=zh_cn&edition=full","pubTime":"2025-07-22 12:19","pubTimestamp":1753157963,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日,内克塔治疗成交额为1485.21万美元,成交额较昨日减少48.00%,当日成交量为59.80万股。内克塔治疗于2025年7月21日跌0.6%,报24.79美元,该股过去5个交易日涨1.56%,年初至今涨77.71%,过去60日涨140.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722121927a45b3b62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722121927a45b3b62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2552945903","title":"内克塔治疗7月17日成交额为3353.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552945903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552945903?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:16","pubTimestamp":1752812171,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日,内克塔治疗成交额为3353.97万美元,成交额较昨日增加45.96%,当日成交量为131.13万股。内克塔治疗于2025年7月17日涨10.48%,报26.67美元,该股过去5个交易日涨6.25%,年初至今涨91.18%,过去60日涨184.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121612a6b1307b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121612a6b1307b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2552170681","title":"内克塔治疗7月16日成交额为2297.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552170681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552170681?lang=zh_cn&edition=full","pubTime":"2025-07-17 12:15","pubTimestamp":1752725742,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日,内克塔治疗成交额为2297.95万美元,成交额较昨日减少16.15%,当日成交量为95.85万股。内克塔治疗于2025年7月16日涨1.43%,报24.14美元,该股过去5个交易日涨3.34%,年初至今涨73.05%,过去60日涨153.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717121544a6aed4b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717121544a6aed4b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2551619579","title":"内克塔治疗盘中异动 早盘股价大跌5.13%报23.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551619579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551619579?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:25","pubTimestamp":1752593125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日23时25分,内克塔治疗股票出现异动,股价快速跳水5.13%。截至发稿,该股报23.16美元/股,成交量33.2685万股,换手率1.92%,振幅6.45%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体跌幅为0.25%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152325259543a405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152325259543a405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2551187618","title":"内克塔治疗盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187618?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:19","pubTimestamp":1752506361,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时19分,内克塔治疗股票出现波动,股价急速下挫5.04%。截至发稿,该股报23.75美元/股,成交量21.5865万股,换手率1.25%,振幅5.56%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为1.12%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423192297a5d5fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423192297a5d5fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2550100607","title":"内克塔治疗7月10日成交额为3959.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550100607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550100607?lang=zh_cn&edition=full","pubTime":"2025-07-11 12:23","pubTimestamp":1752207829,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,内克塔治疗成交额为3959.46万美元,成交额较昨日增加33.42%,当日成交量为162.34万股。内克塔治疗于2025年7月10日涨7.45%,报25.1美元,该股过去5个交易日跌1.68%,年初至今涨79.93%,过去60日涨170.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711122350a443e9cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711122350a443e9cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2550650854","title":"内克塔治疗盘中异动 股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650854?lang=zh_cn&edition=full","pubTime":"2025-07-10 02:12","pubTimestamp":1752084764,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日02时12分,内克塔治疗股票出现波动,股价快速上涨5.46%。截至发稿,该股报23.97美元/股,成交量70.8537万股,换手率4.10%,振幅5.98%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为1.29%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710021245953c6ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710021245953c6ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2549525045","title":"内克塔治疗盘中异动 股价大跌5.20%报22.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549525045?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:45","pubTimestamp":1751985936,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时45分,内克塔治疗股票出现波动,股价大幅下跌5.20%。截至发稿,该股报22.25美元/股,成交量30.5693万股,换手率1.77%,振幅6.94%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为1.00%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708224536979e73bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708224536979e73bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2549558645","title":"内克塔治疗盘中异动 早盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558645?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:35","pubTimestamp":1751895302,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时35分,内克塔治疗股票出现波动,股价快速下挫5.05%。截至发稿,该股报23.51美元/股,成交量7.4079万股,换手率0.43%,振幅3.31%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体跌幅为0.59%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213503979d185d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213503979d185d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2548821304","title":"内克塔治疗7月2日成交额为5274.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548821304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548821304?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:19","pubTimestamp":1751516384,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,内克塔治疗成交额为5274.27万美元,成交额较昨日减少45.05%,当日成交量为207.64万股。内克塔治疗于2025年7月2日涨3.82%,报25.53美元,该股过去5个交易日跌12.33%,年初至今涨83.01%,过去60日涨208.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703121947a4cc7ba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703121947a4cc7ba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2548596228","title":"内克塔治疗7月1日成交额为9598.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548596228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548596228?lang=zh_cn&edition=full","pubTime":"2025-07-02 12:13","pubTimestamp":1751429605,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,内克塔治疗成交额为9598.57万美元,成交额较昨日增加47.65%,当日成交量为386.81万股。内克塔治疗于2025年7月1日跌4.84%,报24.59美元,该股过去5个交易日涨0.57%,年初至今涨76.27%,过去60日涨172.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702121335a729b7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702121335a729b7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":1},{"id":"2547097479","title":"内克塔治疗盘中异动 早盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097479?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:34","pubTimestamp":1751290446,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时34分,内克塔治疗股票出现异动,股价大幅上涨5.88%。截至发稿,该股报27.28美元/股,成交量18.9228万股,换手率1.53%,振幅3.38%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.21%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213406a4c6c554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213406a4c6c554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":1},{"id":"2546576707","title":"内克塔治疗6月26日成交额为2.17亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546576707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546576707?lang=zh_cn&edition=full","pubTime":"2025-06-27 12:05","pubTimestamp":1750997105,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日,内克塔治疗成交额为2.17亿美元,成交额较昨日减少73.99%,当日成交量为703.98万股。内克塔治疗于2025年6月26日涨1.92%,报29.68美元,该股过去5个交易日涨244.72%,年初至今涨112.76%,过去60日涨190.98%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627120514a4c042af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627120514a4c042af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":1},{"id":"2546524942","title":"美股异动 | Nektar Therapeutics(NKTR.US)大涨近30% 湿疹治疗药物临床研究取得超预期积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2546524942","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546524942?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:25","pubTimestamp":1750861546,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周三,Nektar Therapeutics大涨近30%,报31.70美元。消息面上,Nektar此前公布,其用于治疗中重度特应性皮炎的药物 Rezpegaldesleukin在REZOLVE-AD 2b 期临床研究中取得超预期的积极结果,达到主要和次要终点,验证了公司以新型调节性T细胞治疗炎症性皮肤疾病的全新思路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1309805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4007","NKTR","LENZ","BK4539"],"gpt_icon":0},{"id":"2546424576","title":"内克塔治疗盘中异动 快速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546424576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546424576?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:37","pubTimestamp":1750858662,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时37分,内克塔治疗股票出现异动,股价急速上涨5.24%。内克塔治疗股票所在的生物技术行业中,整体跌幅为0.54%。内克塔治疗公司简介:Nektar Therapeutics 是一家制药公司,专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。消息层面,截至21时37分,《HC Wainwright & Co.:维持Nektar Therapeutics评级,由买入调整至买入评级, 目标价由6.50美元调整至120.00美元。》资讯为影响内克塔治疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213743978e8206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213743978e8206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2546261451","title":"创新药重磅消息!“T细胞黑马”Nektar湿疹疗效炸裂,股价单日暴涨150%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546261451","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546261451?lang=zh_cn&edition=full","pubTime":"2025-06-25 11:54","pubTimestamp":1750823674,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,在周二美股交易时间段,全球创新药领域传来一则重磅消息,推动Nektar Therapeutics股价在美股盘中一度暴涨超180%,截至当日美股收盘收涨156%至24.450美元。其中超过3000 万人为特应性皮炎患者,这种皮肤病通常被称为湿疹。在这之后,“首款 Treg 机制湿疹药”这一概念迅速发酵,投资者们非常看好其与现有 Dupixent 等药物错位竞争,最终Nektar Therapeutics股价单日暴涨超150%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1309387.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"创新药重磅消息!“T细胞黑马”Nektar湿疹疗效炸裂,股价单日暴涨150%","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NKTR"],"gpt_icon":1},{"id":"2546723237","title":"HC Wainwright & Co.:维持Nektar Therapeutics(NKTR.US)评级,由买入调整至买入评级, 目标价由6.50美元调整至120.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546723237","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546723237?lang=zh_cn&edition=full","pubTime":"2025-06-25 00:41","pubTimestamp":1750783299,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Nektar Therapeutics(NKTR.US)评级,由买入调整至买入评级, 目标价由6.50美元调整至120.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/25004151284672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NKTR"],"gpt_icon":0},{"id":"2544098449","title":"内克塔治疗盘中异动 早盘快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544098449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544098449?lang=zh_cn&edition=full","pubTime":"2025-06-18 23:10","pubTimestamp":1750259419,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日23时10分,内克塔治疗股票出现波动,股价大幅拉升5.04%。截至发稿,该股报9.17美元/股,成交量8.2092万股,换手率0.66%,振幅6.82%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.97%。内克塔治疗公司简介:Nektar Therapeutics 是一家制药公司,专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618231019a710bb46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618231019a710bb46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nektar.com","stockEarnings":[{"period":"1week","weight":-0.118},{"period":"1month","weight":-0.1183},{"period":"3month","weight":0.922},{"period":"6month","weight":0.747},{"period":"1year","weight":0.0786},{"period":"ytd","weight":0.5541}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.1153},{"period":"6month","weight":0.0503},{"period":"1year","weight":0.1475},{"period":"ytd","weight":0.0785}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nektar Therapeutics于1990年在加州成立,并于1998年重新在特拉华州注册。该公司是一家临床阶段、研究型药物发现生物制药公司,专注于发现和开发免疫治疗领域的创新药物。在这个不断增长的领域内,该公司致力于创造新的免疫调节剂,选择性地诱导、放大、减弱或阻止免疫反应,以达到预期的治疗效果。","yearOnYearQuotes":[{"month":1,"riseRate":0.548387,"avgChangeRate":0.042868},{"month":2,"riseRate":0.516129,"avgChangeRate":0.003089},{"month":3,"riseRate":0.387097,"avgChangeRate":-0.002052},{"month":4,"riseRate":0.451613,"avgChangeRate":0.01158},{"month":5,"riseRate":0.354839,"avgChangeRate":0.003107},{"month":6,"riseRate":0.40625,"avgChangeRate":0.024924},{"month":7,"riseRate":0.4375,"avgChangeRate":-0.019557},{"month":8,"riseRate":0.451613,"avgChangeRate":0.034164},{"month":9,"riseRate":0.483871,"avgChangeRate":0.014638},{"month":10,"riseRate":0.354839,"avgChangeRate":-0.028591},{"month":11,"riseRate":0.677419,"avgChangeRate":0.089799},{"month":12,"riseRate":0.612903,"avgChangeRate":0.027386}],"exchange":"NASDAQ","name":"内克塔治疗","nameEN":"Nektar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"内克塔治疗,NKTR,内克塔治疗股票,内克塔治疗股票老虎,内克塔治疗股票老虎国际,内克塔治疗行情,内克塔治疗股票行情,内克塔治疗股价,内克塔治疗股市,内克塔治疗股票价格,内克塔治疗股票交易,内克塔治疗股票购买,内克塔治疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}